Want to join the conversation?
$PCLN 2Q15 PR: Total revenues were $2.3Bil compared to $1.9Bil in 2Q14. GAAP net income applicable to common shareholders was $517MM or $9.94 per diluted share compared to $576MM or $10.89 per diluted share in the same period a year ago.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.